BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 31, 2022
View Archived Issues
Targeting secretogranin III induces antiangiogenic effect during choroidal neovascularization
Read More
Dual Kv7 channel/TPSO receptor activator GRT-X shows promise in a refractory seizure model
Read More
Betta Pharmaceuticals discovers CD73 inhibitors
Read More
New MET/MERTK/TRYO3/AXL inhibitors identified at Aucentra Therapeutics
Read More
New IL-17RA antagonists presented by Hitgen
Read More
Shanghai Institute of Materia Medica patents glucose-lowering agents
Read More
Chengdu Fanxi Biopharma identifies PPAR-alpha and/or PPAR-delta agonists
Read More
New antipsychotic shows partial agonist activity at DRD2/3 and 5-HT1AR with little 5-HT2AR binding
Read More
STI-1558 strongly inhibits Omicron variant in cell-based assays
Read More
ATH-434 demonstrates efficacy in preclinical multiple system atrophy
Read More
Design of a next-generation cell-based therapy against diabetes
Read More
Improved retinal transplants ready for clinical trials
Read More
IDE-161 enters IND-enabling studies
Read More